Figure 2.
Impact of metabolic comorbidities on copeptin levels. Copeptin plasma concentrations did not differ between ICU patients with or without pre‐existing type 2 diabetes (A) or obesity, as defined by a body‐mass index (BMI) above 30 kg/m² (B)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.